PTPN1 and type 2 diabetes mellitus: The second approach was a type 2 diabetes enzymatic assay, used for the identification of molecules that are able to inhibit Protein Tyrosine Phosphatase 1B (PTP-1B), which arrests the signalling of the insulin receptor in vivo and is essential for the physiological control of glycaemia increase in insulin-responsive tissues [10].